Private Life Sciences Company Call Series

Oppenheimer & Co. Inc.
June 24, 2020

Monday, June 29 – Thursday, July 2, 2020

Virtual

We are pleased to invite you to a virtual call series highlighting the next generation of life sciences private companies from Monday, June 29^th – Thursday, July 2^nd, 2020. We will be hosting the companies for 35 minute presentations with time for Q&A over the four days.

Participating Companies as of June 18 :

Alpha Tau Medical, Amplo Biotechnology, Artios Pharma Inc., Aruna Bio, Atrin Pharmaceuticals, BioSight Pharma, Cadent Therapeutics, Caribou Biosciences, Carisma Therapeutics, Cingulate Therapeutics, Decibel Therapeutics, Dynacure, Eureka Therapeutics, Excision BioTherapeutics, FogPharma, Foghorn Therapeutics, Glycostem, Immunocore, Intensity Therapeutics, Kuur Therapeutics, Lava Therapeutics, NodThera, Obsidian Therapeutics, Ohana Biosciences, Palvella Therapeutics, ReAlta Life Sciences, Inc., Sensei BioTherapeutics, Shape Therapeutics, Tempest Therapeutics, Triplet Therapeutics, Viramal

Agenda

Time	Company	Presenter
1:30 PM ET	Artios Pharma Inc. Click here to join Artios Pharma Inc.	Niall Martin, CEO
2:15 PM ET	Lava Therapeutics Click here to join Lava Therapeutics	Stephen Hurly, CEO
3:00 PM ET	Eureka Therapeutics Click here to join Eureka Therapeutics	Dr. Cheng Liu, President and CEO
3:45 PM ET	Obsidian Therapeutics Click here to join Obsidian Therapeutics	Paul Wotton, CEO Ryan Daws, CFO
4:30 PM ET	Tempest Therapeutics Click here to join Tempest Therapeutics	Tom Dubensky, CEO Steve Brady, President & COO

Time	Company	Presenter
8:00 AM ET	Glycostem Click here to join Glycostem	Troels Jordansen, CEO
8:45 AM ET	TBA
9:30 AM ET	ReAlta Life Sciences, Inc. Click here to join ReAlta Life Sciences	Ulrich Thienel, MD, PhD, Chief Executive Officer
10:15 AM ET	Excision BioTherapeutics Click here to join Excision BioTherapeutics	Daniel Dornbusch, CEO
11:00 AM ET	Triplet Therapeutics Click here to join Triplet Therapeutics	Nessan Bermingham, Founder, President & CEO
11:45 AM ET	Amplo Biotechnology Click here to join Amplo Biotechnology	Patricio Sepulveda, CEO Al Hawkins, President
12:30 PM ET	PANEL: Zooming to a Cure: Oncology BD in the Time of COVID Click here to join panel	Panelists: Chris Sheldon, Vice President, Global Head of Business Development & Licensing, Oncology R&D, AstraZeneca Rachael Lester, VP Corporate Development, Harpoon Therapeutics Marc Ceulemans, Head of Strategic Venture Capital Fund, Pharma Equities , Novartis AG Niels P. Emmerich, Ph.D., Vice President, Global Head Search and Evaluation, AbbVie Derek DiRocco, Ph.D., Principal, Investments, RA Capital Management Vanessa Bhark, Senior Associate, Life Sciences, Frazier Healthcare Partners Oppenheimer Host: Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking
1:30 PM ET	Intensity Therapeutics Click here to join Intensity Therapeutics	Lewis H. Bender, CEO Dr. Ian B. Walters, Chief Medical Officer
2:15 PM ET	Alpha Tau Medical Alpha Tau Medical	Raphi Levy, CFO
3:00 PM ET	Cingulate Therapeutics Click here to join Cingulate Therapeutics	Shane J. Schaffer, PharmD, Chairman & CEO Laurie Myers, COO Lou Van Horn, CFO Matthew Brams, MD, CMO Raul Silva, MD, CSO
3:45 PM ET	Sensei Biotherapeutics Click here to join Sensei Biotherapeutics	John Celebi, President & CEO Rob Pierce, Chief Scientific Officer Marie-Louise Fjaellskog, Chief Medical Officer
4:30 PM ET	FogHorn Click here to join FogHorn	Allan Reine, MD, Chief Financial Officer Adrian Gottschalk, Chief Executive Officer

Time	Company	Presenter
8:00 AM ET	NodThera Click here to join NodThera	Adam Keeney, CEO
8:45 AM ET	Immunocore Click here to join Immunocore	Bahija Jallal, CEO Brian DiDonato, CFO & Head of Strategy
9:30 AM ET	Biosight Pharma Click here to join BioSight Pharma	TBA
10:15 AM ET	Decibel Therapeutics Click here to join Decibel Therapeutics	Laurence Reid, CEO
11:00 AM ET	Dynacure Click here to join Dynacure	Stephane Van Rooijen, CEO
11:45 AM ET	FogPharma Click here to join FogPharma	Greg Verdine, Co-Founder & CEO Tony Gibney, CFO & CBO
12:30 PM ET	PANEL: Alternative Paths to Going Public APOs including Reverse Mergers, Form-10s & SPACs Click here to join panel	Panelists: Jay File, CFO, Evofem Biosciences, Inc. (EVFM) Adam Cutler, CFO, Molecular Templates, Inc. (MTEM) Scott Morenstein, Managing Director, Life Sciences Investing, CAM Capital Keith W. Marshall, Ph.D., M.B.A., Former Executive Vice President, Chief Operating Officer, and Chief Financial Officer, Conatus Pharmaceuticals Mike Celano, CFO, Larimar Therapeutics, Inc. Vishal Kapoor, President, Amplitude Healthcare Acquisition Company Oppenheimer Host: Michael A. Margolis, R.Ph., Co-Head of Healthcare Investment Banking Stefan Loren, Ph.D., Managing Director, Healthcare Investment Banking
1:30 PM ET	Carisma Therapeutics Click here to join Carisma Therapeutics	Steven Kelly, CEO & President
2:15 PM ET	Kuur Therapeutics Click here to join Kuur Therapeutics	Kevin S. Boyle, Sr., Chief Executive Officer Kurt C. Gunter , Chief Medical Officer
3:00 PM ET	Ohana Biosciences Click here to join Ohana Biosciences	Amber Salzman, President & CEO
3:45 PM ET	Viramal Click here to join Viramal	Oliver Bates, CEO
4:30 PM ET	Caribou Biosciences Click here to join Caribou Biosciences	Rachel Haurwitz, President and CEO

Time	Company	Presenter
8:00 AM ET	Atrin Click here to join Atrin	Oren Gilad, CEO Rich Fitzgerald, CFO
8:45 AM ET	Palvella Therapeutics Click here to join Palvella Therapeutics	Wes Kaupinen, President and CEO
9:30 AM ET	Cadent Therapeutics Click here to join Cadent Therapeutics	Jodie Morrison, CEO John McBride, CFO Tim Piser, CSO Chris Kenney, CMO Nicole Luosey, VP, Strategic and Program Operations
10:15 AM ET	Aruna Bio Click here to join Aruna Bio	Mark Sirgo, Chief Executive Officer
11:00 AM ET	Shape Therapeutics Click here to join Shape Therapeutics	Francois Vigneault, PhD, President and CEO John Suliman, CFO